Company Analysis

LivaNova PLC (LIVN)

Nasdaq: LIVN · Electromedical & Electrotherapeutic Apparatus · London, GB · filing with the SEC since 2015
Grade5.3
◀ Past 4.7● Present 5.8▶ Future 5.3

Who owns LivaNova PLC

As filed with the SEC
Holders of 5% or more
3
Blackrock, Inc. holds 12.7% of Common Stock, as its SCHEDULE 13G/A filed Jul 18, 2025 says.
Directors and officers
19
report now, of 46 people on the record since 2015. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 3 named at left.
Holders of 5% or moreshare of the class, as filed
Blackrock, Inc.
12.7%
Primecap Management Co/ca/
SCHEDULE 13G/A · filed Feb 12, 2026 · COM · 8.76% in Feb 13, 2025
7.74%
Fmr LLC
5.8%
Millennium Management LLC
SCHEDULE 13G/A · filed Apr 30, 2026 · Ordinary Shares, par value GBP 1.00 per share · reported falling below 5%, from 6.4% in Feb 9, 2026
under 5%
What LIVN reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
Ceribell, Inc.
An investee · investee · invested in, named in the 10-K filed Feb 25, 2026

45 subsidiaries in 31 countries, from the list filed with the 10-K filed Feb 25, 2026.

Insider tradesForm 4
7sales
0purchases
0sales on a scheduled plan
3people selling
$1.0Msold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
17181920212223242526
2026 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window3 of 48 on the roster
PersonRole as filedSalesSoldOn a planBuysBought
Bianchi Francescodirector4$600,00000$0
Tezel AhmetChief Innovation Officer1$200,00000$0
Story Brookedirector2$200,00000$0
SI Assistanton LIVN · research, not advice